KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synopsys (SNPS) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Synopsys (SNPS) over the last 16 years, with Oct 2024 value amounting to $4.1 billion.

  • Synopsys' Cash & Equivalents rose 40.81% to $2.6 billion in Q3 2025 from the same period last year, while for Jul 2025 it was $2.6 billion, marking a year-over-year increase of 40.81%. This contributed to the annual value of $4.1 billion for FY2024, which is 155.45% up from last year.
  • According to the latest figures from FY2024, Synopsys' Cash & Equivalents is $4.1 billion, which was up 155.45% from $1.6 billion recorded in FY2023.
  • Synopsys' Cash & Equivalents' 5-year high stood at $4.1 billion during FY2024, with a 5-year trough of $1.2 billion in FY2020.
  • Moreover, its 3-year median value for Cash & Equivalents was $1.6 billion (2023), whereas its average is $2.4 billion.
  • Per our database at Business Quant, Synopsys' Cash & Equivalents decreased by 1.07% in 2022 and then spiked by 155.45% in 2024.
  • Yearly analysis of 5 years shows Synopsys' Cash & Equivalents stood at $1.2 billion in 2020, then increased by 15.93% to $1.4 billion in 2021, then dropped by 1.07% to $1.4 billion in 2022, then increased by 11.67% to $1.6 billion in 2023, then spiked by 155.45% to $4.1 billion in 2024.